LINC and UTI are two of the most directly comparable names in the American career-education sector. Both train students for skilled trades, automotive, healthcare, and technical careers, and both are riding the same macro tailwind of a widening U.S. skills gap. Yet their recent stock behavior and fundamentals have diverged meaningfully. This stock comparison is relevant for investors and traders evaluating relative performance and market positioning within a single industry, particularly those looking to identify which name currently offers stronger momentum, more consistent execution, and a clearer catalyst path. I also checked this using Tickeron’s AI Screener to see how the stocks compare to others in the industry.
LINC, through its Lincoln Tech brand, operates roughly 22 campuses across 12 states, offering programs in skilled trades, automotive, health sciences, and information technology. In recent weeks, the company delivered its strongest operating update in several quarters. Revenue rose by a double-digit percentage, driven by a rebound in new student starts, which had slowed sharply earlier in the year. Management raised its full-year revenue guidance and expanded its share repurchase authorization, signaling confidence in the outlook. Sentiment improved as the company regained enrollment momentum through diversified recruitment channels, including high school outreach, social media, and referrals. Despite the recent rally, the stock still trades well below its 52-week high, a contrast that has attracted attention from investors focused on relative performance.
UTI is a larger, more diversified workforce-solutions provider operating through two divisions: its namesake transportation and skilled-trades campuses and its Concorde Career Colleges healthcare segment. The company continues to grow its top line and student counts, aided by new campus openings that have exceeded early expectations. However, recent quarters have been defined by profitability pressure. Heavy strategic investment in expansion, a mix shift toward shorter-duration programs, and softer high school enrollments in certain channels led management to lower its fiscal 2026 guidance, including a meaningful reduction in adjusted EBITDA. This guidance reset weighed on sentiment, and the stock has experienced substantial drawdowns over the trailing several months, even as the long-term growth narrative remains intact.
The two companies share a common industry but differ in scale, structure, and near-term trajectory. UTI is the larger enterprise, with a bigger market capitalization, broader healthcare exposure through Concorde, and a more aggressive campus-expansion program. That expansion drives long-term growth potential but currently suppresses margins and free cash flow. LINC is smaller and more focused, with a narrower footprint and a higher-margin profile that has allowed it to raise guidance while managing costs. On momentum, LINC holds the edge after reaccelerating student starts and beating expectations, whereas UTI faces the weight of a guidance cut and an elevated earnings multiple. Risk factors also differ: LINC faces litigation headlines and elevated student-acquisition costs, while UTI contends with execution risk tied to rapid campus buildout and a shift toward lower-margin programs.
Based on observable factors such as trend consistency, stability, catalyst momentum, and relative positioning, Tickeron's AI would currently favor LINC over UTI. The reasoning rests on LINC's reaccelerating student starts, upward guidance revision, and improving earnings trajectory, which contrast with UTI's guidance reset and ongoing margin compression. This assessment reflects a probabilistic read on current momentum and positioning rather than a definitive outcome, and conditions can shift as new data emerges. When I reviewed the setup with Tickeron’s AI Trend Prediction Engine, the contrast became even clearer.
In my own work, I frequently turn to Tickeron’s AI Trading Bots to test how various automated approaches perform across names like these. The platform lets me compare momentum, swing, and longer-horizon strategies, along with their historical statistics, which helps me put the current divergence between LINC and UTI into broader context without replacing my fundamental review.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
LINC moved above its 50-day moving average on November 10, 2026 date and that indicates a change from a downward trend to an upward trend. In 48 of 55 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 87%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where LINC's RSI Oscillator exited the oversold zone, 19 of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on LINC as a result. In 75 of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.
The Moving Average Convergence Divergence (MACD) for LINC just turned positive on November 10, 2026. Looking at past instances where LINC's MACD turned positive, the stock continued to rise in 33 of 44 cases over the following month. The odds of a continued upward trend are 75%.
Following a +6.86% 3-day Advance, the price is estimated to grow further. Considering data from situations where LINC advanced for three days, in 254 of 314 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
LINC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LINC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
The Aroon Indicator for LINC entered a downward trend on November 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. LINC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 65 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 71 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LINC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock better than average.
The Tickeron Valuation Rating of 84 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: LINC's P/B Ratio (2.768) is slightly higher than the industry average of (1.158). P/E Ratio (23.865) is within average values for comparable stocks, (8.484). Projected Growth (PEG Ratio) (1.557) is also within normal values, averaging (1.327). Dividend Yield (0.005) settles around the average of (4.151) among similar stocks. P/S Ratio (1.383) is also within normal values, averaging (27.566).
The Tickeron PE Growth Rating for this company is 90 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of higher education degrees, job training and vocational study programs
Industry OtherConsumerSpecialties